[1]
|
Heo, Y.-A. (2021) Budesonide/Glycopyrronium/Formoterol: A Review in COPD. Drugs, 81, 1411-1422.
https://doi.org/10.1007/s40265-021-01562-6
|
[2]
|
Global Initiative for Chronic Obstructive Lung Disease (2021) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. http://www.goldcopd.org/
|
[3]
|
王秀丽. LABA/LAMA对慢阻肺急性加重的影响[J]. 系统医学, 2019, 4(10): 44-45+48.
|
[4]
|
王钦坤. 布地奈德福莫特罗粉吸入剂联合噻托溴铵治疗慢性阻塞性肺疾病患者的临床效果[J]. 医疗装备, 2018, 31(19): 138-139.
|
[5]
|
刘志强, 张敏, 陈光喜, 等. 噻托溴铵辅助布地奈德和福莫特罗复方制剂对老年慢性阻塞性肺疾病患者呼吸困难评分尧肺部通气功能及血气分析指标的影响[J]. 中国老年学杂志, 2018, 38(10): 2389-2391.
|
[6]
|
Miravitlles, M., Kawayama, T. and Dreher, M. (2022) LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations. Journal of Clinical Medicine, 11, Article No. 6623.
https://doi.org/10.3390/jcm11226623
|
[7]
|
Zhang, S., King, D., Rosen, V.M. and Ismaila, A.S. (2020) Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review. International Journal of Chronic Obstructive Pulmonary Disease, 15, 417-438. https://doi.org/10.2147/COPD.S234823
|
[8]
|
唐静, 徐光亮. 浅谈COPD稳定期支气管扩张剂的应用[J]. 临床合理用药杂志, 2015(31): 94-95.
https://doi.org/10.15887/j.cnki.13-1389/r.2015.31.062
|
[9]
|
赵瑜, 王惠丽, 王来成, 等. 糖皮质激素联合支气管扩张剂治疗哮喘合并小气道损伤患儿的临床效果[J]. 中国实用医刊, 2020, 47(8): 92-95.
|
[10]
|
李倩, 毛山. 双长效支气管扩张剂在慢性阻塞性肺疾病治疗中的研究进展[J]. 世界临床药物, 2020, 41(2): 149-154.
https://doi.org/10.13683/j.wph.2020.02.014
|
[11]
|
Alagha, K., Palot, A., Sofalvi, T., et al. (2014) Long-Acting Muscarinic Receptor Antagonists for the Treatment of Chronic Airway Diseases. Therapeutic Advances in Chronic Dis-ease, 5, 85-98.
https://doi.org/10.1177/2040622313518227
|
[12]
|
Hanania, N.A. and O’Donnell, D.E. (2019) Activity-Related Dyspnea in Chronic Obstructive Pulmonary Disease: Physical and Psychological Consequences, Unmet Needs, and Fu-ture Directions. International Journal of Chronic Obstructive Pulmonary Disease, 14, 1127-1138. https://doi.org/10.2147/COPD.S188141
|
[13]
|
Dekhuijzen, P.N.R., Hass, N., Liu, J. and Dreher, M. (2020) Daily Impact of COPD in Younger and Older Adults: Global Online Survey Results from over 1300 Patients. COPD: Journal of Chronic Obstructive Pulmonary Disease, 17, 419-428. https://doi.org/10.1080/15412555.2020.1788526
|
[14]
|
Schneider, L.P., Furlanetto, K.C., Rodrigues, A., Lopes, J.R., Hernandes, N.A. and Pitta, F. (2018) Sedentary Behaviour and Physical Inactivity in Patients with Chronic Obstructive Pulmonary Disease: Two Sides of the Same Coin? COPD: Journal of Chronic Obstructive Pulmonary Disease, 15, 432-438.
https://doi.org/10.1080/15412555.2018.1548587
|
[15]
|
(1995) Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease. American Thoracic Society. American Journal of Respiratory and Critical Care Medicine, 152, S77-S121.
|
[16]
|
Hohlfeld, J.M., Vogel-Claussen, J., Biller, H., et al. (2018) Effect of Lung Deflation with Indacaterol plus Glycopyrronium on Ventricular Filling in Patients with Hyperinflation and COPD (CLAIM): A Double-Blind, Randomised, Crossover, Placebo-Controlled, Single-Centre Trial. The Lancet Respiratory Medicine, 6, 368-378.
https://doi.org/10.1016/S2213-2600(18)30054-7
|
[17]
|
Suissa, S., Dell’Aniello, S. and Ernst, P. (2017) Concurrent Use of Long-Acting Bronchodilators in COPD and the Risk of Adverse Cardiovascular Events. European Respiratory Journal, 49, Article ID: 1602245.
https://doi.org/10.1183/13993003.02245-2016
|
[18]
|
Powll, C.E., Watson, C.S. and Gametchu, B. (1999) Immu-noaffinity Isolation of Native Membrane Glucocorticoid Receptor from S-49++ Lymphoma Cells: Biochemical Character-ization and Interaction with Hsp 70 and Hsp 90. Endocrine, 10, 271-280. https://doi.org/10.1007/BF02738626
|
[19]
|
(1987) Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and Asthma. This Official Statement of the American Thoracic Society Was Adopted by the ATS Board of Directors, November 1986. American Review of Respiratory Disease, 136, 225-244.
|
[20]
|
Brown, H.M., Storey, G. and George, W.H.S. (1972) Beclomethasone Dipropionate: A New Steroid Aerosol for the Treatment of Allergic Asthma. BMJ: British Medical Journal, 1, 585-590. https://doi.org/10.1136/bmj.1.5800.585
|
[21]
|
Pauwels, R.A., Buist, A.S., Calverley, P.M.A., Jenkins, C.R. and Hurd, S.S. (2001) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 163, 1256-1276. https://doi.org/10.1164/ajrccm.163.5.2101039
|
[22]
|
Celli, B.R., MacNee, W., et al. (2004) Standards for the Diag-nosis and Treatment of Patients with COPD: A Summary of the ATS/ERS Position Paper. European Respiratory Jour-nal, 23, 932-946.
https://doi.org/10.1183/09031936.04.00014304
|
[23]
|
Vanfleteren, L., Fabbri, L.M., Papi, A., Petruzzelli, S. and Celli, B. (2018) Triple Therapy (ICS/LABA/LAMA) in COPD: Time for a Reappraisal. International Journal of Chronic Obstructive Pulmonary Disease, 13, 3971-3981.
https://doi.org/10.2147/COPD.S185975
|